Management Discussion and Analysis Writing Techniques for Hong Kong Prospectuses

The SFC and HKEX’s joint consultation conclusions on the proposed enhancement of the listing regime, published in December 2024, have placed a renewed focus on the quality and verifiability of financial disclosures in prospectuses, particularly the Management Discussion and Analysis (MD&A) section. The new rules, effective for listing applications submitted on or after 1 July 2025, mandate a more granular breakdown of revenue by operating segment and geographic market, alongside a stricter requirement to reconcile any material variances between prospectus forecasts and actual post-listing financial performance. For a CFO or company secretary preparing a listing application on the Main Board or GEM, the MD&A is no longer a narrative summary of historical financials; it is the primary document that the Listing Division will scrutinise for compliance with the new disclosure standards. A poorly drafted MD&A is now the single most common reason for extended regulatory queries, adding an average of 8 to 12 weeks to the vetting timeline according to 2024 HKEX data. This article outlines the specific drafting techniques required to meet these heightened standards, focusing on the structural, analytical, and risk-disclosure mechanics that survive a Listing Committee review.

The Structural Mandate Under the New Listing Regime

The MD&A must be structured to answer the specific questions the Listing Division will ask under the revised Chapter 11 of the Main Board Listing Rules and Chapter 7 of the GEM Rules, effective 1 July 2025. The section is no longer a freeform narrative; it must follow a prescribed sequence of analysis.

Segment Reporting and Geographic Allocation

The new rules require that the MD&A’s revenue analysis be presented at the same level of disaggregation as the segment reporting in the audited financial statements, per HKFRS 8. For a company with operations in both the PRC and Southeast Asia, each geographic market must be separately discussed. The rule change (HKEX Listing Decision LD150-2024) explicitly states that a single “Asia” line item is insufficient if the company derives more than 15% of its total revenue from any single jurisdiction outside the PRC. The analysis must include a table showing absolute revenue, percentage of total, and year-on-year growth rates for each material segment. The narrative must then explain the drivers behind the percentage change, citing specific contracts, customer wins, or pricing adjustments. A common drafting error is to state “revenue increased due to strong demand” without naming the specific contract or customer group that drove the increase. The Listing Division will query this as a “generic assertion” and require a specific reference to the underlying transaction.

Variance Analysis and Forecast Reconciliation

For any profit forecast or projection included in the prospectus—whether in the “Summary” or “Business” section—the MD&A must contain a reconciliation table comparing the forecast to actual results for the latest interim period. This requirement, codified in the revised Practice Note 22, applies even if the forecast was only an internal target disclosed in the sponsor’s due diligence report. The table must show the forecast figure, the actual figure, the absolute variance, and the percentage variance, with a narrative explanation for any variance exceeding 10%. For example, if a company forecasted HKD 500 million in revenue for the six months ended 30 June 2025 but achieved HKD 420 million, the MD&A must explain whether the shortfall was due to a delayed contract signing, a pricing concession, or a volume decline. The explanation must be supported by a reference to the specific contract or customer relationship. Failure to provide this reconciliation is now a ground for the Listing Division to refuse to proceed with the hearing under Listing Rule 9.03(1).

Analytical Depth: Moving Beyond Descriptive Reporting

The MD&A must demonstrate a cause-and-effect analysis, not a chronological recounting of events. The SFC’s 2023 enforcement report on IPO prospectuses identified “descriptive MD&A” as the most common deficiency, found in 38% of the cases reviewed.

Gross Margin Decomposition

Gross margin analysis must be decomposed into its three components: unit selling price, unit cost, and sales mix. For a manufacturer, the MD&A should show a table with the average selling price (ASP) per unit, the average cost per unit, and the gross margin percentage for each major product line. The narrative must explain the movement in each component. For instance, if the gross margin improved from 28% to 32%, the analysis must attribute the improvement to a specific factor—e.g., a 5% increase in ASP due to the introduction of a premium product line (Product X, launched in Q2 2024), a 3% decline in raw material costs (specifically, polypropylene prices falling from USD 1,200 per tonne to USD 1,100 per tonne), or a shift in sales mix towards higher-margin products (Product Y, whose share of total revenue rose from 15% to 22%). Each factor must be quantified. A statement like “gross margin improved due to better cost control” will be queried.

Operating Expense Analysis

The analysis of selling, general, and administrative (SG&A) expenses must break down the fixed and variable components. The Listing Division will look for a table showing SG&A as a percentage of revenue, with a separate line for each major expense category—e.g., staff costs, marketing expenses, and professional fees. The narrative must explain why the ratio changed. For a company that saw SG&A drop from 18% to 15% of revenue, the explanation might be that a specific marketing campaign for a product launch ended (e.g., the “Brand X” campaign for the new smartphone model, which cost HKD 10 million in 2023 but was not repeated in 2024). The MD&A must also disclose any non-recurring items, such as listing expenses, and show the adjusted SG&A ratio excluding those items. This adjusted ratio is the figure the Listing Division uses to assess the company’s ongoing cost structure.

Risk Disclosure and Forward-Looking Statements

The MD&A must integrate risk disclosure into the financial analysis, not relegate it to a separate “Risk Factors” section. The HKEX’s 2024 thematic review of prospectus disclosures found that 62% of MD&A sections failed to link financial trends to specific risk factors.

Linking Financial Trends to Specific Risks

For each material financial trend—revenue growth, margin compression, or working capital deterioration—the MD&A must identify the primary risk that could cause the trend to reverse. For example, if revenue growth is driven by a single customer (Customer A, representing 40% of total revenue), the MD&A must state: “The concentration of revenue in Customer A exposes the Group to a risk of material revenue decline if this customer terminates its contract. The Group’s contract with Customer A is for a fixed term ending 31 December 2026, with no automatic renewal clause.” This statement links the financial trend (revenue concentration) to a specific risk (contract expiry) and provides a concrete timeline. The same logic applies to supplier concentration, foreign exchange exposure, or regulatory changes. For a biotech company, if R&D expenses are rising, the MD&A must note that the company’s cash runway, based on the current burn rate of HKD 50 million per quarter, extends only to Q3 2026, and that a failure to secure additional funding or achieve a milestone payment would require a material reduction in R&D activity.

Forward-Looking Statements and Safe Harbor

Any forward-looking statement in the MD&A—such as a projection of revenue growth or margin targets—must be accompanied by a clear basis of preparation and a sensitivity analysis. The basis must state the key assumptions (e.g., “assumes an exchange rate of USD 1 = HKD 7.80 and a 5% increase in unit volume”). The sensitivity analysis must show the impact of a 10% adverse change in each assumption on the projected figure. For a company projecting HKD 1 billion in revenue for the next year, the MD&A should include a table showing that a 10% decline in ASP would reduce revenue by HKD 100 million, and a 10% decline in volume would reduce revenue by HKD 90 million. This analysis is required under the revised SFC Code of Conduct for Sponsors (paragraph 17.6), which mandates that all projections in a prospectus must include a quantified sensitivity test. The MD&A is the correct location for this analysis, as it sits within the financial discussion.

Mechanics of Drafting: Language, Tables, and Cross-Referencing

The drafting mechanics must follow the HKEX’s prescribed format, as outlined in the “Guide on Drafting Prospectuses” (2024 edition). The MD&A is a legal document, not a marketing brochure.

Table Format and Numbering

All financial tables in the MD&A must be numbered consecutively (e.g., Table 1, Table 2) and must include a title that states the period covered (e.g., “Table 1: Revenue by Operating Segment for the Years Ended 31 December 2022, 2023, and 2024”). The table must show absolute figures in HKD (or the reporting currency) and percentages. Every table must be self-contained; the reader should not need to refer to the financial statements to understand the table. The narrative text must reference each table by its number. For example, “As shown in Table 1, revenue from the PRC segment grew by 15%, while the Southeast Asia segment declined by 8%.” This cross-referencing is a mechanical requirement the Listing Division checks during the first-round review. A table without a narrative reference is considered orphaned and will be queried.

Language and Tone

The MD&A must use precise, factual language. Avoid any subjective adjectives—e.g., “significant,” “substantial,” “strong,” “robust.” Instead, quantify the magnitude. Replace “the company experienced strong revenue growth” with “revenue grew by 18.4%, from HKD 500 million to HKD 592 million.” Use the active voice where possible: “the increase in revenue was driven by the launch of Product X” is preferred over “revenue increased due to the launch of Product X.” The passive voice is acceptable only when the actor is unknown or irrelevant—e.g., “the contract was terminated on 30 June 2025.” Every sentence must be verifiable against the financial statements or the sponsor’s due diligence work papers. The Listing Division will test the MD&A’s assertions against the underlying documents during the vetting process.

Cross-Referencing to Other Prospectus Sections

The MD&A must contain explicit cross-references to the “Business,” “Risk Factors,” and “Use of Proceeds” sections. For example, when discussing capital expenditure, the MD&A should state: “As discussed in the ‘Business’ section under ‘Capital Expenditure Plan,’ the Group expects to spend HKD 100 million in 2026 on the new production facility in Vietnam.” This cross-referencing creates a coherent document and prevents contradictions between sections. The Listing Division checks for consistency: if the MD&A says revenue is driven by a single product, but the “Business” section lists five products as key revenue drivers, the discrepancy will be flagged. The cross-reference must be specific, citing the exact subsection title and page number.

Actionable Takeaways

1. Structure the MD&A to mirror the segment reporting in the audited financial statements, with a separate table and narrative for each operating segment that meets the 15% materiality threshold under the revised Listing Rules.
2. Include a mandatory variance reconciliation table for any profit forecast or projection disclosed in the prospectus, showing actual versus forecast figures with a narrative explanation for variances exceeding 10%.
3. Decompose gross margin analysis into unit selling price, unit cost, and sales mix, with each component quantified and attributed to a specific contract or market event.
4. Link every material financial trend to a specific risk factor, providing a concrete timeline or event that could cause the trend to reverse.
5. Use numbered, self-contained tables with explicit cross-references in the narrative text, and avoid all subjective adjectives by replacing them with precise numerical data.